Financial law

Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on Oatly Group AB (Nasdaq: OTLY)

Retrieved on: 
Wednesday, July 14, 2021

As a reminder, our full report, along with its investment disclaimers, can be downloaded and viewed at www.SprucePointCap.com .

Key Points: 
  • As a reminder, our full report, along with its investment disclaimers, can be downloaded and viewed at www.SprucePointCap.com .
  • As disclosed, Spruce Point has a short position in Oatly Group AB and owns derivative securities that stand to net benefit if its share price falls.
  • Spruce Point Capital Management, LLC is a forensic fundamentally-oriented investment manager that focuses on short-selling, value and special situation investment opportunities.
  • Spruce Point Capital Management, LLC is a member of the Financial Industry Regulatory Authority, CRD number 288248.

Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc

Retrieved on: 
Wednesday, July 14, 2021

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

Form 8.3 - The Vanguard Group, Inc.: Aon plc

Retrieved on: 
Wednesday, July 14, 2021

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

Results of the June 2021 survey on credit terms and conditions in euro-denominated securities financing and over-the-counter derivatives markets (SESFOD)

Retrieved on: 
Wednesday, July 14, 2021

13 July 2021

Key Points: 
  • 13 July 2021

    Overall credit terms and conditions in euro-denominated securities financing and over-the-counter (OTC) derivatives markets tightened slightly over the March 2021 to May 2021 review period.

  • Survey respondents reported a tightening of overall credit terms for each individual counterparty type except banks/dealers, hedge funds and sovereigns, for which overall credit terms remained unchanged.
  • Respondents expected overall terms to tighten somewhat further over the June 2021 to August 2021 review period.
  • The June 2021 survey collected qualitative information on changes between March 2021 and May 2021.

Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc

Retrieved on: 
Tuesday, July 13, 2021

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

Form 8.3 - The Vanguard Group, Inc.: Aon plc

Retrieved on: 
Tuesday, July 13, 2021

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

Form 8.3 - The Vanguard Group, Inc.: UDG Healthcare plc

Retrieved on: 
Tuesday, July 13, 2021

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

Banking Expert Shawn Hibbs Joins Payrailz as VP of Bank Sales

Retrieved on: 
Tuesday, July 13, 2021

Payrailz , a digital payments company offering smarter, more engaging payment experiences to banks and credit unions across the United States, announced it has hired Shawn Hibbs as Vice President of Bank Sales.

Key Points: 
  • Payrailz , a digital payments company offering smarter, more engaging payment experiences to banks and credit unions across the United States, announced it has hired Shawn Hibbs as Vice President of Bank Sales.
  • Hibbs has over 25 years of experience in consultative sales, with 15 of those years being focused in the financial services industry.
  • With this extensive background in payments and banking, Hibbs is already in tune with what thought-leading banks require of a payments provider, and he understands what works best for them.
  • In his new role with Payrailz, he will now connect banks across the country with Payrailz smart payments hub using Payrailz proprietary API-first infrastructure.

Olink Holding AB (publ) Launches Public Offering of American Depositary Shares by Selling Shareholders

Retrieved on: 
Monday, July 12, 2021

The U.K. Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Offering.

Key Points: 
  • The U.K. Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Offering.
  • The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the offering.
  • Furthermore, it is noted that, notwithstanding the Target Market Assessment, the underwriters will only procure investors who meet the criteria of professional clients or eligible counterparties.
  • Each distributor is responsible for undertaking its own target market assessment in respect of the securities and determining appropriate distribution channels.

Form 8.3 - The Vanguard Group, Inc.: Aon plc

Retrieved on: 
Monday, July 12, 2021

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO